UTI Mutual Fund launches UTI CRISIL SDL Maturity April 2033 Index Fund

NFO period: 12^th December – 19^th December, 2022

Highlights of the NFO:

• Scheme type – An open-ended target maturity debt index fund tracking CRISIL IBX SDL Index – April 2033. A Relatively High Interest Rate Risk and Relatively Low Credit Risk


• Investment objective – The investment objective of the scheme is to track the Index by investing in securities as represented by CRISIL IBX SDL Index – April 2033, subject to tracking errors. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.


• Product suitability – The product is suitable for investors who are seeking income over the target maturity period by investing in State Development Loans (SDLs), tracking CRISIL IBX SDL Index April 2033, subject to tracking error.


• Minimum Application Amount – First investment is Rs. 5,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available – Regular Plan and Direct Plan having Growth Option only.


• Fund Manager – Shri Sunil Patil


• Benchmark – CRISIL IBX SDL Index – April 2033